Open an account

RF Acquisition Corp II

RFAI · NASDAQ

$26.15−$8.35 (−24.20%)TodayMarket closed ·
Prev close $34.50

About RFAI

RF Acquisition Corp. II operates as a blank check company. The firm is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination. The firm intends to initially focus its search on target businesses in Asia within the technology sector, including artificial intelligence, quantum computing, and biotechnology. The company has no operations and has not generated any revenue.

Employees
0
Headquarters
Singapore
Listed
May 17, 2024
Sector
N/A
Industry
N/A

RFAI key statistics

Market cap
104.55M
Price-earnings ratio
0.00
Dividend yield
—
Average volume
8.38K
Volume
9.84K
Open price
$34.99
High today
$34.60
Low today
$26.01
52 Week high
$73.00
52 Week low
$8.94

RF Acquisition Corp II (RFAI) at a glance

As of Oct 23, 2026, RF Acquisition Corp II (RFAI) shares are priced at $26.15, giving the company a market cap of 104.55M and a price-to-earnings ratio of 0.00.

Today the stock has traded between $26.01 and $34.60. The current price is 0.5% above the day's low and 24.4% below its high.

Volume so far is 9.84K shares, in line with the average of 8.38K shares a day.

Over the past year RF Acquisition Corp II has ranged from $8.94 to $73.00, and now sits 27% of the way up that range.

RFAI news

  • Avi Kapoor

    Nasdaq Down 150 Points; Chicago Fed National Activity Index Drops In July

  • Press releasePRNewswire

    The9 Reports US$32 Million Net Income for Second Quarter of 2026, Up Over 39% Sequentially

  • Avi Kapoor

    Gold Moves Higher; US Composite PMI Surges In August

  • Avi Kapoor

    Dow Jumps 350 Points; BJ's Wholesale Club Posts Upbeat Earnings

  • Henry Khederian

    RF Acquisition Corp. Stock Skyrockets Following Key SEC Filings

  • Mohd Haider

    Werewolf Therapeutics (HOWL) Stock Is Trending Overnight—Here's Why It Jumped 90% After Hours

  • Mohd Haider

    RF Acquisition Corp (RFAI) Stock Jumps Nearly 500% After Hours: Why It Is Trending

  • Press releasePRNewswire

    AI Drug Discovery Pioneer, Nanyang Biologics Pte. Ltd., Enters into Business Combination Agreement with RF Acquisition Corp II in US$1.5B Transaction to Pursue Public Listing

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.